This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: University of Florida Research Foundation Inc., University of Kansas. Active years: 2022.
Location History:
- Gainesville, FL (US) (2022)
- Gainsville, FL (US) (2022)
Company Filing History:
2 out of 3,043 
1 out of 571 
Years Active: 2022
Title: Laura E Hanold: Innovator in Cancer Treatment
Introduction
Laura E Hanold is a prominent inventor based in Gainesville, FL (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented technologies. With a total of 2 patents, her work focuses on developing methods and compositions that target cancer cell growth.
Latest Patents
One of her latest patents is titled "Macrocyclic peptides to decrease c-Myc protein levels and reduce cancer cell growth." This technology provides methods and medicaments useful for treating prostate cancer and breast cancer. The methods include administering at least one of cyclo[Phe-D-Pro-Phe-Trp] and cyclo[Phe-D-Pro-Phe-D-Trp] to a subject suffering from these types of cancer. Another significant patent is "Macrocyclic peptides and derivatives thereof with opioid activity." This invention relates to macrocyclic peptides and pharmaceutical compositions that modulate opioid receptor activity.
Career Highlights
Laura has worked with esteemed institutions such as the University of Florida Research Foundation Inc and the University of Kansas. Her research has been pivotal in advancing the understanding and treatment of cancer.
Collaborations
Some of her notable coworkers include Jane V Aldrich and Archana Mukhopadhyay. Their collaborative efforts have contributed to the success of her research projects.
Conclusion
Laura E Hanold is a dedicated inventor whose work in cancer treatment continues to impact the medical field positively. Her innovative patents and collaborations highlight her commitment to advancing healthcare solutions.